Pacemaker implantation in active COVID-19 patients: experience of a city hospital

Aim. To analyze the experience of a multidisciplinary hospital in the implantation of pacemaker (PM) in patients with COVID-19, to evaluate predictors and the incidence of complications and adverse outcomes. Methods. One-hundred twenty five patients with active COVID-19 underwent PM implantation/rep...

Full description

Saved in:
Bibliographic Details
Published in:Vestnik aritmologii Vol. 29; no. 4; pp. 17 - 25
Main Authors: Repnikov, I. O., Chakhunashvili, D. Z., Evtushenko, A. E., Maslova, E. V., Akhobadze, M. V., Marapov, D. I., Perchatkin, D. I.
Format: Journal Article
Language:English
Published: 08-12-2022
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aim. To analyze the experience of a multidisciplinary hospital in the implantation of pacemaker (PM) in patients with COVID-19, to evaluate predictors and the incidence of complications and adverse outcomes. Methods. One-hundred twenty five patients with active COVID-19 underwent PM implantation/replacement during the period from 04/01/2020 to 11/30/2021 at the Department of Cardiovascular Surgery of the City Multidisciplinary Hospital, reprofiling to provide medical care to patients with COVID-19. The presence of SARS-CoV-2 virus was confirmed by a positive result of the polymerase chain reaction performed the day before the procedure. Results. Median age of patients was 81 [73-86] years. Indications for PM in most cases were atrioventricular block of II-III degrees (n=71, 56.8%), sick sinus syndrome (n=30, 24%). The PM was replaced in 20 (16%) patients. Of the 125 patients in the study survey, the 30-day complication rate was 12%, and the 180-day mortality rate was 16.8%. Conclusion. Patients with active COVID-19 had an increased level of complications and mortality rates after PM implantation/replacement. It is necessary to take these risks into consideration to better select patients with active COVID-19 infection.
ISSN:1561-8641
2658-7327
DOI:10.35336/VA-2022-4-03